Characterization of MHC Class I and ß-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.
Pediatr Blood Cancer
; 63(4): 618-26, 2016 Apr.
Article
in En
| MEDLINE
| ID: mdl-26575538
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Histocompatibility Antigens Class I
/
Clinical Trials as Topic
/
Beta 2-Microglobulin
/
Patient Selection
/
Immunotherapy
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Pediatr Blood Cancer
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Year:
2016
Document type:
Article
Country of publication: